Vitra Labs

Vitra Labs is a biotechnology company pioneering the field of in vitro oogenesis (IVO) to address the global rise in infertility. The company is developing a platform that aims to generate functional human eggs (oocytes) from a patient's own blood cells using induced pluripotent stem cell (iPSC) technology. By recapitulating the process of oogenesis outside the body, Vitra Labs seeks to eliminate the dependency on egg donors and provide a biological solution for individuals facing age-related or medical infertility. Spun out of research from the Gladstone Institutes, Vitra Labs utilizes advanced cellular reprogramming and single-cell sequencing to restore youthful gene expression and developmental potential in cells. The company's mission is to make reproductive options safer, more accessible, and more effective for millions of patients worldwide.